Subverted macrophages in the triple-negative breast cancer ecosystem

被引:7
作者
Shang, Linxiao [1 ]
Zhong, Yuting [2 ]
Yao, Yan [2 ]
Liu, Cun [3 ]
Wang, Lu [4 ]
Zhang, Wenfeng [5 ]
Liu, Jingyang [2 ]
Wang, Xue [4 ]
Sun, Changgang [6 ,7 ]
机构
[1] Binzhou Med Univ, Sch Integrated Tradit Chinese & Western Med, Yantai 264000, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250022, Peoples R China
[3] Weifang Med Univ, Coll Tradit Chinese Med, Weifang 261000, Peoples R China
[4] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan 250022, Peoples R China
[5] Macau Univ Sci & Technol, Sch Tradit Chinese Med, Macau 999078, Peoples R China
[6] Weifang Tradit Chinese Hosp, Dept Oncol, Weifang 261000, Peoples R China
[7] Weifang Tradit Chinese Hosp, Dept Oncol, Weifang, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor -associated macrophage; Triple-negative breast cancer; Target; Immunosuppression; Subvert; TUMOR-ASSOCIATED MACROPHAGES; MONOCLONAL-ANTIBODY THERAPY; CHECKPOINT BLOCKADE; CELLS; MICROENVIRONMENT; POLARIZATION; RESISTANCE; RECEPTOR; NANOPARTICLES; PHAGOCYTOSIS;
D O I
10.1016/j.biopha.2023.115414
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tumor-associated macrophages (TAMs) are the most critical effector cells of innate immunity and the most abundant tumor-infiltrating immune cells. They play a key role in the clearance of apoptotic bodies, regulation of inflammation, and tissue repair to maintain homeostasis in vivo. With the progression of triple-negative breast cancer(TNBC), TAMs are "subverted" from tumor-promoting immune cells to tumor-promoting immune suppressor cells, which play a significant role in tumor development and are considered potential targets for cancer therapy. Here, we explored how macrophages, as the most important part of the TNBC ecosystem, are "subverted" to drive cancer evolution and the uniqueness of TAMs in TNBC progression and metastasis. Similarly, we discuss the rationale and available evidence for TAMs as potential targets for TNBC therapy.
引用
收藏
页数:14
相关论文
共 50 条
[41]   Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets [J].
Lv, Yan ;
Ma, Xiao ;
Du, Yuxin ;
Feng, Jifeng .
ONCOTARGETS AND THERAPY, 2021, 14 :589-607
[42]   Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer [J].
Cao, Xu ;
Li, Bolei ;
Chen, Jing ;
Dang, Jessica ;
Chen, Siqi ;
Gunes, E. Gulsen ;
Xu, Bo ;
Tian, Lei ;
Muend, Sabina ;
Raoof, Mustafa ;
Querfeld, Christiane ;
Yu, Jianhua ;
Rosen, Steven T. ;
Wang, Yingyu ;
Feng, Mingye .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (03)
[43]   BAG3 is a negative regulator of ciliogenesis in glioblastoma and triple-negative breast cancer cells [J].
Linder, Benedikt ;
Klein, Caterina ;
Hoffmann, Marina E. ;
Bonn, Florian ;
Dikic, Ivan ;
Koegel, Donat .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (01) :77-90
[44]   Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort [J].
Goncalves, Homero, Jr. ;
Guerra, Maximiliano Ribeiro ;
Duarte Cintra, Jane Rocha ;
Fayer, Vivian Assis ;
Brum, Igor Vilela ;
Bustamante Teixeira, Maria Teresa .
CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2018, 12
[45]   Immunosuppressive microenvironment of liver restrains chemotherapeutic efficacy in triple-negative breast cancer [J].
Liu, Mingduo ;
Qian, Mengjia ;
Sun, Wen ;
Sun, Xiaowei ;
Sun, Yue ;
Yu, Muxin ;
Tang, Xinyu ;
Mao, Xinrui ;
Sun, Chang ;
Qi, Qi ;
Zhang, Weiya ;
Ling, Peiwen ;
Pang, Zheng ;
Li, Wei ;
Pan, Hong ;
Wang, Shui ;
Zhou, Wenbin .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
[46]   Detachable Liposomes Combined Immunochemotherapy for Enhanced Triple-Negative Breast Cancer Treatment through Reprogramming of Tumor-Associated Macrophages [J].
Chen, Mingshu ;
Miao, Yunqiu ;
Qian, Kun ;
Zhou, Xin ;
Guo, Linmiao ;
Qiu, Yu ;
Wang, Rui ;
Gan, Yong ;
Zhang, Xinxin .
NANO LETTERS, 2021, 21 (14) :6031-6041
[47]   Tailored therapies for triple-negative breast cancer: current landscape and future perceptions [J].
Khan, Yumna ;
Rizvi, Sana ;
Raza, Ali ;
Khan, Amna ;
Hussain, Sadique ;
Khan, Najeeb Ullah ;
Alshammari, Saud O. ;
Alshammari, Qamar A. ;
Alshammari, Abdulkarim ;
Ellakwa, Doha El-Sayed .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
[48]   Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review [J].
Lu, Boya ;
Natarajan, Elango ;
Balaji Raghavendran, Hanumantha Rao ;
Markandan, Uma Devi .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
[49]   Comprehensive Analysis of the Implication of PGRMC1 in Triple-Negative Breast Cancer [J].
Xu, Xin ;
Ruan, Xiangyan ;
Zhang, Ying ;
Cai, Guiju ;
Ju, Rui ;
Yang, Yu ;
Cheng, Jiaojiao ;
Gu, Muqing .
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
[50]   PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim [J].
Byerly, Jessica H. ;
Port, Elisa R. ;
Irie, Hanna Y. .
BREAST CANCER RESEARCH, 2020, 22 (01)